LifeStance Health Group (NASDAQ:LFST) Stock Price Up 4.5% - Should You Buy?

Key Points

• LifeStance Health Group shares rose 4.5% to $5.40, despite a 40% decline in trading volume compared to average sessions.
• Analysts have issued predominantly positive ratings, with UBS raising its price target to $9.00 and a consensus rating of "Moderate Buy" reflected among analysts.
• The company's latest financial results showed a revenue increase of 10.6% year-over-year, with an EPS of ($0.01), which is better than analysts' expectations.

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report)'s share price rose 4.5% on Thursday . The company traded as high as $5.39 and last traded at $5.40. Approximately 1,180,048 shares changed hands during trading, a decline of 40% from the average daily volume of 1,960,861 shares. The stock had previously closed at $5.17.

Analyst Upgrades and Downgrades

LFST has been the topic of a number of research analyst reports. Wall Street Zen upgraded LifeStance Health Group from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. UBS Group upped their target price on LifeStance Health Group from $8.50 to $9.00 and gave the company a "buy" rating in a report on Friday, August 8th. Finally, BTIG Research started coverage on LifeStance Health Group in a research note on Friday, July 25th. They issued a "buy" rating and a $8.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $8.50.

LifeStance Health Group Price Performance

The stock has a market capitalization of $2.08 billion, a P/E ratio of -107.00 and a beta of 1.13. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.48 and a current ratio of 1.48. The firm has a fifty day moving average price of $4.67 and a two-hundred day moving average price of $6.04.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.02. The business had revenue of $345.31 million during the quarter, compared to the consensus estimate of $345.05 million. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The business's quarterly revenue was up 10.6% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.06) EPS. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, analysts expect that LifeStance Health Group, Inc. will post -0.18 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Ujjwal Ramtekkar sold 16,000 shares of LifeStance Health Group stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total transaction of $95,040.00. Following the transaction, the insider directly owned 113,435 shares in the company, valued at approximately $673,803.90. The trade was a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 6.60% of the company's stock.

Institutional Investors Weigh In On LifeStance Health Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale bought a new stake in shares of LifeStance Health Group during the 1st quarter valued at $31,000. Park Edge Advisors LLC purchased a new stake in shares of LifeStance Health Group during the second quarter worth about $52,000. Bayesian Capital Management LP bought a new stake in LifeStance Health Group during the 2nd quarter valued at approximately $52,000. Xponance Inc. bought a new stake in shares of LifeStance Health Group during the first quarter valued at approximately $69,000. Finally, Public Employees Retirement System of Ohio purchased a new position in shares of LifeStance Health Group in the second quarter worth $70,000. Institutional investors own 85.50% of the company's stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.